Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 9
2003 3
2004 8
2005 9
2006 6
2007 8
2008 12
2009 10
2010 3
2011 8
2012 10
2013 8
2014 7
2015 18
2016 14
2017 12
2018 20
2019 9
2020 13
2021 15
2022 18
2023 7
2024 4
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
Socially-integrated transdisciplinary HIV prevention.
Friedman SR, Downing MJ Jr, Smyrnov P, Nikolopoulos G, Schneider JA, Livak B, Magiorkinis G, Slobodianyk L, Vasylyeva TI, Paraskevis D, Psichogiou M, Sypsa V, Malliori MM, Hatzakis A. Friedman SR, et al. Among authors: hatzakis a. AIDS Behav. 2014 Oct;18(10):1821-34. doi: 10.1007/s10461-013-0643-5. AIDS Behav. 2014. PMID: 24165983 Free PMC article.
HBV virological assessment.
Hatzakis A, Magiorkinis E, Haida C. Hatzakis A, et al. J Hepatol. 2006;44(1 Suppl):S71-6. doi: 10.1016/j.jhep.2005.11.017. Epub 2005 Nov 28. J Hepatol. 2006. PMID: 16343681 Review.
Why START? Reflections that led to the conduct of this large long-term strategic HIV trial.
INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group; Lundgren J, Babiker A, Gordin F, Emery S, Fätkenheuer G, Molina JM, Wood R, Neaton JD. INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group, et al. HIV Med. 2015 Apr;16 Suppl 1(0 1):1-9. doi: 10.1111/hiv.12227. HIV Med. 2015. PMID: 25711317 Free PMC article. No abstract available.
Securing sustainable funding for viral hepatitis elimination plans.
Hatzakis A, Lazarus JV, Cholongitas E, Baptista-Leite R, Boucher C, Busoi CS, Deuffic-Burban S, Chhatwal J, Esmat G, Hutchinson S, Malliori MM, Maticic M, Mozalevskis A, Negro F, Papandreou GA, Papatheodoridis GV, Peck-Radosavljevic M, Razavi H, Reic T, Schatz E, Tozun N, Younossi Z, Manns MP. Hatzakis A, et al. Liver Int. 2020 Feb;40(2):260-270. doi: 10.1111/liv.14282. Epub 2019 Dec 5. Liver Int. 2020. PMID: 31808281 Review.
Molecular epidemiology of HIV-1 infection in Europe: An overview.
Beloukas A, Psarris A, Giannelou P, Kostaki E, Hatzakis A, Paraskevis D. Beloukas A, et al. Among authors: hatzakis a. Infect Genet Evol. 2016 Dec;46:180-189. doi: 10.1016/j.meegid.2016.06.033. Epub 2016 Jun 16. Infect Genet Evol. 2016. PMID: 27321440 Review.
HIV outbreaks among people who inject drugs in Europe, North America, and Israel.
Des Jarlais DC, Sypsa V, Feelemyer J, Abagiu AO, Arendt V, Broz D, Chemtob D, Seguin-Devaux C, Duwve JM, Fitzgerald M, Goldberg DJ, Hatzakis A, Jipa RE, Katchman E, Keenan E, Khan I, Konrad S, McAuley A, Skinner S, Wiessing L. Des Jarlais DC, et al. Among authors: hatzakis a. Lancet HIV. 2020 Jun;7(6):e434-e442. doi: 10.1016/S2352-3018(20)30082-5. Lancet HIV. 2020. PMID: 32504576 Free PMC article. Review.
212 results